Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Fresenius Kabi Issues Recall of 13 Lots of Ketorolac Tromethamine Injection

americanpharmaceuticalreviewApril 21, 2020

Tag: Fresenius Kabi , Ketorolac Tromethamine Injection , recall

PharmaSources Customer Service